Search Cosmetics & Toiletries

105 Results

Type: News

Section: Cosmetic Ingredients

applyingsunscreenonshoulder850x425

DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol

DSM believes it is important for consumers in the USA to benefit from the efficacy and aesthetics that modern filters such as BEMT can provide. As such, the company is pushing for Monograph status.

Eighteen studies identified complications such as rash, irritation, immune system disorders, stratum corneum DNA damage and hormonal disruption.

Literature Review Connects Sunscreen Absorption with Potential Adverse Effects

A literature review published in Dermatology Research suggests the potential adverse effects, i.e., irritation, rashes, hormone disruption, etc., of sunscreen ingredients absorbed into human skin and present in human plasma and urine.

CT.com_sun1

FDA Reviews Sunscreen Active

The Food and Drug Administration(FDA) has requested safety and efficacy data for the sunscreen active ingredient diethylhexyl butamido triazone in concentrations...

couplejumpingonbeach850x425

Could the FDA Sunscreen Monograph See a New Addition?

It's been decades since the FDA's OTC Sunscreen Monograph welcomed a new addition; back then, it was avobenzone. Now, another could be joining the ranks.

Sunscreen Innovation Act Introduced into Congress to Amend FDA's TEA Program

On Mar. 13, 2014, U.S. Senator Jack Reed (D-RI) and U.S. Congressman Ed Whitfield (R-KY) introduced the bipartisan, bicameral Sunscreen Innovation Act (S. 2141 and H.R. 4250, respectively), which has been supported by the Public Access to SunScreen (PASS) Coalition.

FDA Publishes Opinion on Two Sunscreen TEAs and Is Urged for More Action by PASS

The end of February was busy for the U.S. Food and Drug Administration (FDA), which published two letters on the Time and Extent Applications (TEAs) for diethylhexyl butamido triazone (Uvasorb HEB) and amiloxate (Neo Heliopan E 1000), finding insufficient scientific evidence to claim either as generally recognized as safe and effective (GRASE) and denying their addition to the OTC Sunscreen Monograph.

Sunscreen Innovation Act Passes: What Does it Mean?

The Public Access to SunScreens (PASS) Coalition applauded the U.S. Senate's passage of the Sunscreen Innovation Act (S. 2141). While the Act aims to streamline the approval process for new sunscreen actives, will it? Industry expert David Steinberg gives his take.

FDA to Focus on Nanotech Trend

The FDA announced plans to focus on nanotechnology at a public meeting to be held later this year...

FDA and SDA Address Triclosan Concern

The FDA updated its Web site on Apr. 8, 2010, with its most recent information on triclosan. According to the FDA, triclosan provides a benefit to a number of personal care products, and it does not have sufficient safety evidence to recommend changing consumer use of products that contain triclosan. However, the FDA also did not have evidence that triclosan provided any additional benefit when added to antibacterial soaps and body washes.

FDA Issues New Guidances on Nanotechnology

The US Food and Drug Administration has issued two new draft guidances on the use of nanotechnology by the cosmetics and foods industries.

New Black Pigment Approved By FDA

D&C Black No. 3, or "bone black," has been approved by the US Food and Drug Administration (FDA) for formulation into eye shadow, eyeliner, mascara and face powder.

FDA Petitioned to Assess Nanotech Risk

CTA and a coalition of consumer, health and environmental groups called on the FDA to address nanomaterials in consumer products.

The company’s colorants are sustainable with precision manufacturing practices, offering long shelf life while reducing any food or animal extracts.

RK Pigments Manufactures FDA Batch-certified Colorants

RK Pigments’ colorants are sustainable, processed using precision manufacturing practices and offer long shelf life while reducing any food or animal extracts.

FDA Issues Final Guidance on Nanomaterials

On June 26, 2014, The U.S. Food and Drug Administration (FDA) issued Final Guidance for Industry: Safety of Nanomaterials in Cosmetics, a final guidance document addressing the use of nanotechnology in cosmetics.

850_shampoobottle1

Antibacterial Soap? You Can Skip It, Says FDA

The FDA is issuing a final rule under which OTC consumer antiseptic wash products containing the majority of the antibacterial active ingredients—including triclosan and triclocarban—will no longer be able to be marketed.

MarijuanaCosmeticMortarPestle850x425

FDA Clears the Air on CBD Reform Efforts

While CBD is trending across market segments, the rules in play to ensure public health and market direction are baffling at best. As such, the FDA has issued an update outlining its efforts to provide clarity.

SI_MicroneedlingTools_425

Road to Regulation: Microneedling Devices Defined by FDA

Microneedling devices have, for some time, been without widely enforced regulation. As such, the U.S. Food and Drug Administration released a draft guidance on Sept. 15, 2017, defining when tools are considered esthetic vs. medical in nature, along with potential regulatory changes.

FDA Releases Draft Guidance Toward Nanotech Regulation

The US Food and Drug Administration (FDA) has released a draft guidance outlining its view on how to identify whether regulated products contain nanomaterials or apply such technologies.

Page 1 of 6